Results 141 to 150 of about 1,854,011 (302)

Toward Subcellular Action Potential Detection with Nanodiamond Quantum Magnetometry. [PDF]

Nanomaterials (Basel)
Fathima A, Milas P, Mahtab S, Talukder T, Merritt M, Wachira J, Tadesse S, Spencer M, Ozturk B.   +8 more
europepmc   +1 more source

Predicted sensory consequences of voluntary actions modulate amplitude and temporal dynamics of preceding readiness potentials [PDF]

, 2017
Daniel Reznik, Shiri Simon, Roy Mukamel
openalex   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

Optimal Site of the Reference Electrode for Recording the Compound Muscle Action Potential of the Deltoid Muscle. [PDF]

Muscle Nerve
Hamada Y, Oishi C, Kanbayashi T, Chiba A, Kobayashi S, Sonoo M.   +5 more
europepmc   +1 more source

Effects of lidocaine and procaine on the action potential of cells in the canine sinus node.

, 1980
Hiroyasu Satoh, Keitaro Hashimoto
openalex   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Simulation insights on the compound action potential in multifascicular nerves. [PDF]

PLoS Comput Biol
Tharayil JJ, Zinno C, Agnesi F, Lloyd B, Farcito S, Cassara A, Kuster N, Reimann M, Micera S, Neufeld E.   +9 more
europepmc   +1 more source

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

Molecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli, Alessio Bevilacqua, Mathias Wenes, Denis Migliorini, Lars van der Veen, Sigrid S Skånland, Giusy Di Conza, Kjetil Taskén   +7 more
wiley   +1 more source

The wave nature of the action potential. [PDF]

Front Cell Neurosci
Galinsky VL, Frank LR.
europepmc   +1 more source

Structure and Properties of Vacuum-arc Coatings of Chromium and Its Nitrides Obtained under the Action of Constant and Pulse High-voltage Bias Potential

, 2017
O. V. Sоbоl, А. А. Postelnyk, Ruslan Mygushchenko, Ubeidulla F. Al‐Qawabeha, Taha A. Tabaza, Safwan Al-Qawabah, В. Ф. Горбань, V. А. Stolbovoy   +7 more
openalex   +1 more source